VolitionRx Limited Diluted Shares Outstanding (Weighted Average)
VolitionRx Limited (VNRX) reported Diluted Shares Outstanding (Weighted Average) of 9.15 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- VolitionRx Limited weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 9.15M shares, a 78.36% increase year-over-year.
- VolitionRx Limited weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 6.88M shares, a 42.59% increase year-over-year.
- VolitionRx Limited weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 120.98M shares, a 29.22% increase year-over-year.
- VolitionRx Limited weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 108.21M shares, a 23.13% increase year-over-year.
- VolitionRx Limited weighted average number of shares outstanding, diluted for fiscal 2025 was 106.83M shares, a 23.46% increase from fiscal 2024.
- VolitionRx Limited weighted average number of shares outstanding, diluted for fiscal 2024 was 86.53M shares, a 21.47% increase from fiscal 2023.
- VolitionRx Limited weighted average number of shares outstanding, diluted for fiscal 2023 was 71.23M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 9.15M shares 10-Q · filed 2026-08-13 | 8.02M shares 10-Q · filed 2026-08-13 | 45.67M shares derived: average of 3 quarters · filed 2026-08-13 | 61.31M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | 6.88M shares 10-Q · filed 2026-05-14 | 63.93M shares derived: average of 2 quarters · filed 2026-05-14 | 78.69M shares derived: average of 3 quarters · filed 2026-05-14 | 60.30M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | 120.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 114.60M shares derived: average of 2 quarters · filed 2026-03-31 | 78.11M shares derived: average of 3 quarters · filed 2026-08-13 | 106.83M shares 10-K · filed 2026-03-31 | ||
| 2025-09-30 | 108.21M shares 10-Q · filed 2025-11-13 | 56.67M shares derived: average of 2 quarters · filed 2026-08-13 | 102.12M shares 10-Q · filed 2025-11-13 | 52.95M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | 5.13M shares 10-Q · filed 2026-08-13 | 102.65M shares 10-Q · filed 2025-08-14 | 4.98M shares 10-Q · filed 2026-08-13 | 99.61M shares 10-Q · filed 2025-08-14 | 34.53M shares derived: average of 3 quarters · filed 2026-08-13 | 47.87M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 4.83M shares 10-Q · filed 2026-05-14 | 96.54M shares 10-Q · filed 2025-05-15 | 49.23M shares derived: average of 2 quarters · filed 2026-05-14 | 62.11M shares derived: average of 3 quarters · filed 2026-05-14 | 67.25M shares derived: average of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | 93.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 90.76M shares derived: average of 2 quarters · filed 2026-03-31 | 88.06M shares derived: average of 3 quarters · filed 2026-03-31 | 86.53M shares 10-K · filed 2026-03-31 | ||
| 2024-09-30 | 87.89M shares 10-Q · filed 2025-11-13 | 85.28M shares derived: average of 2 quarters · filed 2025-11-13 | 84.17M shares 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | 82.67M shares 10-Q · filed 2025-08-14 | 82.31M shares 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | 81.96M shares 10-Q · filed 2025-05-15 | |||||
| 2023-12-31 | 71.23M shares 10-K · filed 2025-03-31 | |||||
| 2015-09-30 | 18.04M shares 10-Q · filed 2015-11-04 | 17.99M shares derived: average of 2 quarters · filed 2015-11-04 | 17.50M shares 10-Q · filed 2015-11-04 | |||
| 2015-06-30 | 17.95M shares 10-Q · filed 2015-08-11 | 17.21M shares 10-Q · filed 2015-08-11 | ||||
| 2014-09-30 | 13.52M shares 10-Q · filed 2015-11-04 | 13.71M shares derived: average of 2 quarters · filed 2015-11-04 | 13.06M shares 10-Q · filed 2015-11-04 | |||
| 2014-06-30 | 13.89M shares 10-Q · filed 2015-08-11 | 12.82M shares 10-Q · filed 2015-08-11 | ||||
| 2013-06-30 | 10.64M shares 10-Q · filed 2014-08-01 | 10.43M shares 10-Q · filed 2014-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |